Purpose: To evaluate whether transformation of the naso-lacrimal passage as happens after
dacryocystorhinostomy (DCR) operation has any effect on the systemic
adverse effects of topically administered
timolol maleate . Materials and
Methods: Fifty otherwise healthy
adult patients without any prior
history of cardiac or pulmonary problems scheduled for elective DCR
surgery received a drop of
timolol maleate 0.5% on the healthy
eye . This
eye served as a control. Six weeks after successful DCR
surgery , the operated
eye received the same medication.
Parameters compared included
intraocular pressure (IOP),
pulse rate ,
blood pressure and
forced expiratory volume in the first second (FEV1) findings. Observations Post DCR
patients showed an increased
incidence of reduced
pulse rate and FEV1.
Conclusion: Timolol maleate ophthalmic preparation should be used with caution in post-DCR
patients .